Literature DB >> 15866446

Dosimetric parameters estimation using PENELOPE Monte-Carlo simulation code: Model 6711 a 125I brachytherapy seed.

Edgar A V Rodríguez1, Elmer P Q Alcón, Miguel L Rodriguez, F Gutt, Carlos E de Almeida, E de Almeida.   

Abstract

The dosimetric parameters for characterization of a low-energy interstitial brachytherapy source (125)I are examined. In this work, the radial dose function, g(r), anisotropy function F(r,theta), and the absolute dose rate, Lambda, around (125)I seed model 6711 have been estimated by means of the PENELOPE Monte-Carlo (MC) simulation code. The results obtained are in good agreement with the corresponding values recommended by TG-43 that are based in experimental and MC published results.

Mesh：

Year:  2005        PMID： 15866446     DOI： 10.1016/j.apradiso.2005.02.004

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN： 0969-8043            Impact factor:   1.513


  4 in total

1.  Development of GATE Monte Carlo Code for Simulation and Dosimetry of New I-125 Seeds in Eye Plaque Brachytherapy.

Authors:  Payvand Taherparvar; Zeinab Fardi
Journal:  Nucl Med Mol Imaging       Date:  2021-01-11

Review 2.  Iodine-125 brachytherapy for brain tumours--a review.

Authors:  Silke B Schwarz; Niklas Thon; Katharina Nikolajek; Maximilian Niyazi; Joerg-Christian Tonn; Claus Belka; Friedrich-Wilhelm Kreth
Journal:  Radiat Oncol       Date:  2012-03-06       Impact factor: 3.481

3.  Determination of dosimetric parameters for shielded 153Gd source in prostate cancer brachytherapy.

Authors:  Mahdi Ghorbani; Benyamin Khajetash; Najmeh Ghatei; Mohammad Mehrpouyan; Ali S Meigooni; Ramin Shahraini
Journal:  Radiol Oncol       Date:  2017-02-22       Impact factor: 2.991

4.  Monte Carlo study of a new I-125 brachytherapy prototype seed with a ceramic radionuclide carrier and radiographic marker.

Authors:  Lucas Paixão; Alessandro Facure; Ana Maria M Santos; Adriano Márcio dos Santos; Suely Epsztein Grynberg
Journal:  J Appl Clin Med Phys       Date:  2012-05-10       Impact factor: 2.102
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.